J. Goldman & Co LP Has $19.89 Million Stock Position in ZimVie Inc. (NASDAQ:ZIMV)

J. Goldman & Co LP boosted its position in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 167.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,425,810 shares of the company's stock after acquiring an additional 892,785 shares during the period. J. Goldman & Co LP owned about 5.17% of ZimVie worth $19,890,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Barclays PLC boosted its position in ZimVie by 338.4% during the 3rd quarter. Barclays PLC now owns 43,437 shares of the company's stock worth $690,000 after purchasing an additional 33,529 shares during the period. JPMorgan Chase & Co. increased its holdings in ZimVie by 66.7% in the third quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company's stock valued at $2,911,000 after buying an additional 73,395 shares during the last quarter. Monarch Capital Management Inc. boosted its stake in ZimVie by 6.2% in the fourth quarter. Monarch Capital Management Inc. now owns 65,560 shares of the company's stock valued at $915,000 after acquiring an additional 3,847 shares during the period. SG Americas Securities LLC boosted its stake in ZimVie by 15.7% in the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock valued at $155,000 after acquiring an additional 1,508 shares during the period. Finally, EMC Capital Management boosted its stake in ZimVie by 47.0% in the fourth quarter. EMC Capital Management now owns 13,802 shares of the company's stock valued at $193,000 after acquiring an additional 4,414 shares during the period. 95.63% of the stock is owned by hedge funds and other institutional investors.

ZimVie Price Performance

Shares of NASDAQ ZIMV traded down $0.03 during mid-day trading on Thursday, hitting $8.69. 119,031 shares of the stock were exchanged, compared to its average volume of 214,414. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. The stock's fifty day simple moving average is $10.08 and its two-hundred day simple moving average is $12.55. ZimVie Inc. has a twelve month low of $8.56 and a twelve month high of $22.40. The company has a market cap of $241.99 million, a P/E ratio of -0.66 and a beta of 2.16.

ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.21 by $0.06. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The company had revenue of $112.00 million for the quarter, compared to analysts' expectations of $113.10 million. As a group, analysts forecast that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Needham & Company LLC reiterated a "hold" rating on shares of ZimVie in a research report on Wednesday, April 9th. UBS Group cut their target price on shares of ZimVie from $16.00 to $10.00 and set a "neutral" rating on the stock in a research note on Thursday. Finally, B. Riley initiated coverage on ZimVie in a research report on Thursday, April 10th. They issued a "buy" rating and a $16.00 price target for the company.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.